COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
EPI Health has graciously supported the COVID-19 News and Resource Center.
FREE WEBINAR: COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Next Steps and JDD invites you to attend this webinar panel to provide discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic, COVID-19.
Over the course of the 2 hours, 8 differe …
EPI Health has graciously supported the COVID-19 News and Resource Center.
FREE WEBINAR: COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Next Steps and JDD invites you to attend this webinar panel to provide discussion, guidance, and leadership for dermatologists and dermatology practices during the global coronavirus pandemic, COVID-19.
Over the course of the 2 hours, 8 differe … Continue reading "COVID-19: Urgent Medical and Aesthetic Issues for Dermatology"
In this case series, JDD authors evaluate the efficacy and safety of intralesional triamcinolone acetonide injections (ILK) when used with topical minoxidil in the management of traction alopecia in 6 African American women.
Background
Traction alopecia (TA) is a form of hair loss secondary to repetitive and/or prolonged tension to a hair follicle over an extended period of time. This typically … 
In part 1 of this 2-part series, Dr. Kircik along with JDD authors Vlatka Agnetta MD, Abel Torres MD JD MBA, Seemal R. Desai MD, and Adelaide A. Hebert MD, reviewed the regulatory landscape of compounding in dermatology, including federal and state regulations. In part 2, they discuss FDA and USP Compounding Lists/ Categories and provide their final thoughts on in-office compounding.
FDA Compound … 
Medication compounding is defined as any alteration, mixing, or combining of two or more ingredients that make the drug more specific to the needs of the patient.1 Compounded medications are used widely in patient care to meet their individual medical needs and maximize treatment outcomes. The Food and Drug Administration (FDA) and the United States Pharmacopeia (USP) have been the leading organiz … 
Morphea profunda. To the dermatologist, these words conjure images of hyperpigmented to violaceous, indurated, bound down atrophic plaques. We describe these lesions in our specialty’s vernacular, so that those we are conversing with can often surmise the diagnosis before even seeing the affected patient. But to the patient, it is the language of the diagnosis itself that has the most meaning. M …